Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults

• Main Authors: Pitisuttithum P., Nitayaphan S., Thongcharoen P., Khamboonruang C., Kim J., De Souza M., Chuenchitra T., Garner R.P., Thapinta D., Polonis V., Ratto-Kim S., Chanbancherd P., Chiu J., Birx D.L., Duliege A.-M., McNeil J.G., Brown A.E.
• Format: Article
• Language: English
• Published: 2014
• Online Access: http://www.scopus.com/inward/record.url?eid=2-s2.0-0042315405&partnerID=40&md5=7e77483f572e8a63a72c94c033ffa7db; http://cmuir.cmu.ac.th/handle/6653943832/4358
• Institution: Chiang Mai University

Safety and immunogenicity of 2 recombinant human immunodeficiency virus (HIV) type 1 envelope glycoprotein (gp) 120 vaccines derived from SF2 (subtype B) and CM235 (CRF01_AE, Thai E) were evaluated in 370 Thai adults at low risk of HIV infection. Various doses of CM235 (25, 50, or 100 μg) and SF2 (0...